BlackRock Institutional Trust’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

BlackRock Institutional Trust’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$312K	Hold	161,054	–	–	﹤0.01%	3533
2016 Q3	$1M	Buy	161,054 +90,026	+127%	+$555K	﹤0.01%	3294
2016 Q2	$318K	Sell	71,028 -80,631	-53%	-$526K	﹤0.01%	3576
2016 Q1	$1.59M	Buy	151,659 +22,616	+18%	+$449K	﹤0.01%	3135
2015 Q4	$3.81M	Buy	129,043 +15,936	+14%	+$482K	﹤0.01%	2847
2015 Q3	$3.57M	Buy	113,107 +2,942	+3%	+$141K	﹤0.01%	2867
2015 Q2	$6.52M	Buy	110,165 +5,950	+6%	+$420K	﹤0.01%	2649
2015 Q1	$11.1M	Buy	104,215 +6,954	+7%	+$663K	﹤0.01%	2332
2014 Q4	$9.13M	Buy	97,261 +2,736	+3%	+$261K	﹤0.01%	2417
2014 Q3	$7.26M	Buy	94,525 +12,769	+16%	+$1.01M	﹤0.01%	2503
2014 Q2	$7.34M	Buy	81,756 +26,017	+47%	+$1.59M	﹤0.01%	2604
2014 Q1	$2.98M	Buy	55,739 +8,246	+17%	+$272K	﹤0.01%	2992
2013 Q4	$1.2M	Buy	47,493 +8,439	+22%	+$201K	﹤0.01%	3345
2013 Q3	$1.06M	Buy	39,054 +1,832	+5%	+$59K	﹤0.01%	3339
2013 Q2	$1.34M	Buy	+37,222	New	+$1.4M	﹤0.01%	3239

Other funds holding PTX

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Globeflex Capital San Diego, California $783M AUM 81.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlackRock Institutional Trust's PTX Position: Q4 2016 in Review

BlackRock Institutional Trust held its Pernix Therapeutics Holdings, Inc. (PTX) position steady in Q4 2016 at 161,054 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #3533.

BlackRock Institutional Trust first reported a position in PTX in Q2 2013 and has held it in 15 quarters since. The position peaked at $11.1M in Q1 2015. 34 funds tracked by Wall St. Rank hold PTX as of Q4 2016.

BlackRock Institutional Trust held 161,054 shares of Pernix Therapeutics Holdings, Inc. worth $312K as of Q4 2016.
BlackRock Institutional Trust left its Pernix Therapeutics Holdings, Inc. share count unchanged in Q4 2016.
Pernix Therapeutics Holdings, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3533 holding.
BlackRock Institutional Trust first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Pernix Therapeutics Holdings, Inc. position peaked at $11.1M in Q1 2015.
34 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.